|
Volumn 17, Issue 5, 2001, Pages 856-862
|
High or standard initial dose of budesonide to control mild-to-moderate asthma?
a a a |
Author keywords
Airway pharmacology; Budesonide; Mild to moderate asthma; Treatment strategy
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CONTROL;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LUNG FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NIGHT;
PEAK EXPIRATORY FLOW;
PREDICTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SYMPTOM;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ADULT;
AGED;
ASTHMA;
BUDESONIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
MALE;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
|
EID: 0034948549
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.01.17508560 Document Type: Article |
Times cited : (20)
|
References (25)
|